Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/30/2025

STI Screening Recommendations for Commercial Sex Workers

Core STI Screening Panel

  • The American Academy of Pediatrics recommends that commercial sex workers be screened with nucleic acid amplification tests (NAATs) for chlamydia and gonorrhea, serologic testing for syphilis (both treponemal and non-treponemal tests), HIV testing, and consideration of trichomoniasis testing for females, with screening performed at least annually or every 3-6 months depending on risk factors 1, 2
  • The Centers for Disease Control and Prevention (CDC) suggests that urine NAAT for males and vaginal swab NAAT for females are the preferred methods for chlamydia and gonorrhea screening 3
  • The CDC also recommends that both treponemal and non-treponemal serologic tests are required for syphilis diagnosis, with a traditional approach starting with non-treponemal test (RPR or VDRL) and confirming with treponemal test (TP-PA, enzyme immunoassay, or chemiluminescent immunoassay) 1, 2, 3
  • The US Preventive Services Task Force (USPSTF) recommends standard HIV testing per local protocols 2, 3

Additional Testing for Females

  • The CDC recommends vaginal swab NAAT as the preferred method for trichomoniasis testing in females, with a sensitivity superior to wet mount microscopy 1, 2, 3
  • The CDC suggests that wet mount microscopy has poor sensitivity (60-70%) and should be avoided as the primary screening method for trichomoniasis 1, 2

Screening Frequency

  • The USPSTF explicitly identifies commercial sex workers as a high-risk population requiring regular STI screening, with a minimum of annual screening for all sexually active commercial sex workers 1, 2, 3
  • The CDC recommends screening every 3-6 months for those with additional high-risk factors, including multiple or anonymous partners, sex in conjunction with illicit drug use, partners who participate in high-risk activities, and interim detection of new STIs 3, 6

Post-Treatment Rescreening

  • The CDC recommends rescreening at 3 months after treatment for chlamydia or gonorrhea, regardless of whether partners were treated 6
  • The CDC suggests considering rescreening at 3 months for females previously diagnosed with trichomoniasis 1, 6

Important Clinical Considerations

  • The CDC states that NAATs are strongly preferred over traditional methods because they offer superior sensitivity and can use non-invasive specimens 1, 2
  • The CDC recommends against using Papanicolaou tests to diagnose trichomoniasis due to poor sensitivity and specificity 1, 2
  • The CDC advises against relying on a single positive syphilis test - diagnosis requires both treponemal and non-treponemal results plus comprehensive clinical evaluation 1, 2
  • The CDC recommends against delaying treatment while awaiting test results if clinical suspicion is high - presumptive treatment may be appropriate to prevent ongoing transmission 7